Cited by 130Cardiac Ischemia and ReperfusionSirtuins and Resveratrol in MedicineCardiac Arrest and Resuscitation

Lysine deacetylation in ischaemic preconditioning: the role of SIRT1

Open access
Nadtochiy, Sergiy M., Redman, Emily, Rahman, Irfan, Brookes, Paul S.·2011·Cardiovascular Research

Abstract

AIMS: Acute ischaemic preconditioning (IPC) induces protection against cardiac ischaemia-reperfusion (IR) via post-translational modification of key proteins. Lysine (Lys) acetylation is an important regulator of protein function, but this type of modification has not been studied in the context of IPC. We investigated Lys acetylation in IPC and its upstream regulation by SIRT1. METHODS AND RESULTS: Hearts from C57BL/6 mice were Langendorff-perfused and subjected to IPC and IR injury. Mice were exposed to IPC by in vivo coronary artery occlusion. An isolated cardiomyocyte model of IPC was also developed. Lys acetylation was measured by western blotting, and pharmacological modulators of Lys acetylation were tested. More Lys deacetylation was observed in IPC, in the Langendorff, in vivo, and cellular IPC models; this was concurrent with an increase in SIRT1 activity measured by p53 Lys₃₇₉ deacetylation. IPC was not accompanied by changes in SIRT1 protein level, but evidence was obtained for SIRT1 modification by Small Ubiquitin-like Modifier (SUMOylation) in IPC. Furthermore, the specific SIRT1 inhibitor splitomicin reversed both IPC-mediated Lys deacetylation and IPC-induced cardioprotection. Inhibition of nicotinamide phosphoribosyltransferase (Nampt, an important enzyme which regulates SIRT1 activity by maintaining availability of the substrate NAD(+)) also blocked both IPC-induced deacetylation and cardioprotection. CONCLUSION: Lys deacetylation occurs during IPC and an elevation in SIRT1 activity plays a role in this phenomenon. Inhibition of SIRT1, either directly or by restricting the availability of its substrate NAD(+), inhibits IPC. Together these data suggest a role for SIRT1-mediated Lys deacetylation in the mechanism of acute IPC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cvr/cvq287

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Infarct size was assessed after 120 min reperfusion by triphenyltetrazolium chloride staining and expressed as a percentage of the risk zone as described.

    “We assessed infarct size after 120 min of reperfusion using triphenyltetrazolium chloride staining and expressed it as a percentage of the risk zone as described recently40.”
  • An ischemic preconditioning protocol that protects against subsequent ischemia-reperfusion injury also led to S-nitrosation of ND3 Cys39.

    “Subjecting hearts to an IPC protocol that protects against subsequent ischemia-reperfusion injury40 also led to S-nitrosation of ND3 Cys39 (Supplementary Table 6).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nadtochiy, S. M., Redman, E., Rahman, I., & Brookes, P. S.
Affiliations
University of Rochester Medicine (US)
Venue
Cardiovascular Research
Published
2010-09-07
Volume
89
Issue
3
Pages
643-649
ISSN
  • 0008-6363 (ISSN-L)
  • 1755-3245
OpenAlex
W2128982252
Cited by
130
References
66
Citations by year
2025: 3 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 8 · 2019: 11 · 2018: 7 · 2017: 7 · 2016: 10 · 2015: 7 · 2014: 24 · 2013: 16 · 2012: 12
FWCI
8.47
Type
journal article
Language
en
Open access
Locations
  • Cardiovascular Research (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01hl097751-04)
  • National Heart, Lung, and Blood Institute (HL-097751, HL085613, HL-071158, R01HL085613, R01HL071158)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Keywords
ischemic preconditioning, lysine deacetylation, SIRT1, lysine acetylation, cardioprotection, SUMOylation, visfatin, cardiomyocytes
MeSH terms
Acetylation, Animals, Disease Models, Animal, Lysine, Male, Mice, Inbred C57BL, Myocardium, NAD, Myocardial Reperfusion Injury, Ischemic Preconditioning, Myocardial, Myocytes, Cardiac, Mice, Sirtuin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review